
The precious 'white gold' buried in the Earth
Investors had lost faith in Edwin Drake's obsessive hunt for oil when the American entrepreneur finally struck black gold in an underground reservoir in Titusville, Pennsylvania, in 1859. The discovery spurred an exploration frenzy that launched the modern oil age.
Now, a new generation of wildcatters are racing to replicate that Titusville moment, hoping to bring about the dawn of a major new energy resource. However, it's not fossil fuels they are looking for, but a commercially viable source of natural – and low-carbon – hydrogen.
Hydrogen, the smallest, simplest and lightest molecule on Earth, is currently used mainly for refining and chemical industries, such as producing ammonia for fertilisers. The vast majority of this hydrogen is made from polluting methane gas or coal gasification.
But there are already other, lower-carbon ways to produce hydrogen. And hydrogen's ability to store three times more energy than oil, while only producing water when burnt, has made some view it as an attractive clean fuel option, especially for industries which are hard to decarbonise by electrification, such as aviation, shipping or steel production.
"Green" hydrogen, for example, is a cleaner alternative made by splitting water between hydrogen and oxygen molecules in a process powered by renewable energy. "Blue" hydrogen, made from fossil fuels using carbon capture and storage to reduce the emissions, is another alternative.
Green and blue hydrogen have received huge attention as potential low-carbon fuels in recent years, but they also have significant downsides. Both are expensive and faced challenges and delays in their rollout. And while their use is slowly growing, together they still only make up around 1% of global hydrogen production. Some researchers have also raised doubts over how low-carbon blue hydrogen really is due to associated leaks of methane – a potent greenhouse gas which is 80 times more powerful than carbon dioxide (CO2) over a 20-year time span.
Meanwhile, in recent years scientists have found that naturally occurring hydrogen is actually much more widespread than previously thought, leading some to believe it could be tapped as a cheap and carbon-free fuel.
This "geologic" hydrogen, also called natural or white hydrogen, is produced naturally when underground water encounters iron-rich rocks in a process known as serpentinisation. Because hydrogen is so light, it usually seeps through porous rocks and cracks, eventually rising to the atmosphere. That's if it isn't first consumed in underground reactions or eaten by subterranean microbes.
But in some geological settings, hydrogen can become trapped under rocks with low permeability, such as salt or shale rocks, which create a seal under which the gas can accumulate. It's these hydrogen accumulations in the Earth's subsurface that prospectors hope may be viable for commercial exploitation.
According to a 2024 study from the US Geological Survey (USGS), there could be anywhere between one billion and 10 trillion tonnes of hydrogen in the subsurface, with a best guess of around 5.6 trillion tonnes trapped in geological formations.
Most of this hydrogen is likely to be "in accumulations that are too deep, too far offshore, or too small to be economically recovered", the study's authors, USGS geologists Geoffrey Ellis and Sarah Gelman, wrote. However, if just 2% of this white hydrogen was recoverable, it could meet projected global hydrogen demand for around 200 years, they found. It would also, they added, contain roughly twice as much energy as is stored in all the proven natural gas reserves on Earth.
The idea has sparked huge interest in what could be lying under our feet. At least 60 companies have publicly said they are exploring for white hydrogen, with investment estimated to have reached $1bn (£740m), says Eric Gaucher, a French geochemist who co-leads a white hydrogen expert group convened by the International Energy Agency (IEA).
"That's more or less a rush," he says. Gaucher left a job at oil giant Total four years ago and now runs an independent consultancy advising companies "who want to win the race for natural hydrogen". Exploratory drilling, he notes, has already taken place in Australia and the US.
Prospectors like Gaucher argue the discovery of a commercially viable hydrogen reservoir could usher in a new age of exploration in the same way that Drake's 1859 find fired the starting gun for the oil economy. "The hope is to make a big discovery in the next three or four years," he says. "My dream is that this natural hydrogen can play a role, maybe as oil played in the past."
Still, Gaucher admits prospectors should currently remain "modest" about white hydrogen's potential role in the energy transition. Not least because huge uncertainties remain about how much of it could actually be recoverable from the Earth's mantle.
"Currently, we really have no idea," says Ellis, of the USGS. "That's the big question. From what we know today, there's just too much uncertainty to really make any predictions about how impactful [natural hydrogen] might be."
The only place where white hydrogen extracted from the Earth is currently used is in the village of Bourakebougou in western Mali. The local community's fate changed in 1987 when the cigarette of a worker digging a water well sparked a small explosion as he leaned over the edge. Nearly pure hydrogen was later found at the bottom of the borehole. It is now used to produce electricity for the village.
Odourless, colourless and tasteless, hydrogen is difficult to detect without specifically looking for it. But in early 2025, a team of geologists announced they found a clue for where to start looking.
Using simulations of plate tectonic processes, they showed that rocks that had been pushed closer to the surface during the formation of mountains could be hotspots for white hydrogen. The researchers identified mountain ranges stretching from the Alps to the Himalayas as possible targets for exploration.
Other researchers in the UK and Canada recently published a list of key ingredients needed to find hydrogen-producing underground systems. "We know for example that underground microbes readily feast on hydrogen," study co-author Barbara Sherwood Lollar, a professor of geology at the University of Toronto, said in a release. "Avoiding environments that bring them into contact with the hydrogen is important in preserving hydrogen in economic accumulations."
Although exploration of white hydrogen has been gathering steam, no commercially viable wells have yet been found. In its 2024 global hydrogen review, the IEA described white hydrogen production technology as scoring five out of nine on its technology readiness scale.
There is also still insufficient evidence to prove white hydrogen is even a renewable resource for use at scale, says Laurent Truche, a professor of geochemistry at Grenoble Alpes University in France who researches natural hydrogen. That's because it's not clear whether or not hydrogen is generated quickly enough to replace any that might be extracted from reservoirs. Truche says the rate of hydrogen generation is "several orders of magnitude too slow compared to what we would expect to produce".
He worries about the hype, noting that "natural hydrogen production is currently tiny, the hydrogen that is found is rarely pure, [and] many discoveries are of dissolved gas, which is difficult to produce".
Naturally produced hydrogen is also unlikely to be located where it is needed and hydrogen is difficult to transport and store, although proponents told the BBC it could support fuel sovereignty by powering local industries.
But extracting white hydrogen could also come with unintended consequences, including impacts on the climate that could undo some of the benefits of replacing fossil fuels.
Hydrogen reservoirs can contain methane, which could offset the benefits of white hydrogen unless it were captured. What's more, once in the atmosphere, hydrogen competes with methane for hydroxyl, a compound which breaks down methane molecules. This means that any hydrogen that escapes during extraction would also make methane in the atmosphere last longer and cause even more warming.
These methane emissions, alongside the emissions embedded in drilling infrastructure, mean white hydrogen production wouldn't be totally carbon free.
One initial estimate suggests that, in cases where reservoirs have a high percentage of hydrogen and low amounts of methane, 0.4kg of CO2 equivalent (CO2e) would be emitted for every kilogram of hydrogen produced. That's less than the average 1.6kg CO2e generated with each kilogram of green hydrogen, which requires the construction of vast renewable energy infrastructure.
However, emissions associated with white hydrogen production would increase the more methane is in the reservoir and the less productive the well becomes. A well with 75% hydrogen and 22.5% methane would emit 1.5 kg CO2e per kg of hydrogen, according to the same study.
White hydrogen proponents tell the BBC that methane emissions can be filtered, while extracting and burning hydrogen as a fuel would reduce the amount that naturally leaks to the surface and reaches the atmosphere.
But Truche disagrees. Large-scale white hydrogen production would lead to increased hydrogen leakage into the atmosphere, he says. It could also impact underground ecosystems and the microbial life that rely on hydrogen as an energy source, he adds. These microbes play an important role in the cycle of the Earth's chemical elements and compounds – yet relatively little is known about the deep terrestrial subsurface, according to a scientific review by Rachel Beaver and Josh Neufeld at the University of Waterloo in Canada.
Even if a large discovery was made in the next few years, it would take at least another decade to develop an industry at scale, says Truche, meaning white hydrogen will not have an impact on the energy system anytime soon.
Other experts have also argued white hydrogen extraction "simply won't be available" to replace the fossil fuel-produced hydrogen currently in use within the timeframe needed to meet global climate goals.
For Emmanuel Masini, founder and chief executive of Mantle8, a French hydrogen exploration start-up backed by Bill Gates' Breakthrough Energy, however, the urgent need for decarbonisation is exactly the reason for accelerating white hydrogen exploration.
"We are convinced there could be really significant [hydrogen] reserves, we need to go ahead and deliver them," Masini says.
To do this, Mantle8 has developed a technology which uses geology, geophysics and geochemistry data and sensors to create 4D images (in three dimensions and across time) of the Earth's mantle to pinpoint the specific location of white hydrogen reservoirs and quantify and monitor the volume of hydrogen in each.
The technology could be used to map the entire planet and take out the guesswork in exploration by identifying replenishing reservoirs, saving both time and money, says the start-up. Masini says it has already identified 12 promising locations across Europe and aims to identify 10 million tonnes of hydrogen reserves by 2030 – a goal he is confident it can meet.
More like this:• Why we may soon need to eat 'resurrection' plants• Are China's swap stations the future of electric cars?• The controversial machine sending CO2 to the ocean and making hydrogen
In February 2025, Mantle8 secured financing to pilot the technology in the Pyrenees mountains in southwest France. The company aims to begin exploratory drilling in 2028 and produce its first kilogram of hydrogen by 2030 at around $0.80 (£0.60) per kg. That would make it cheaper than any other hydrogen form and at least five times less than the cost of green hydrogen. Researchers at Stanford University have also estimated that white hydrogen could be produced below $1 (£0.74) per kg under optimal conditions.
Tools and expertise developed by the oil and gas industry could be adapted to extract the gas, argues Viacheslav Zgonnik, a pioneer in natural hydrogen exploration and chief executive of HyReveal, a start-up developing ways to detect and monitor hydrogen underground. "It presents an amazing opportunity for the hydrocarbon industry to make the pivot" to cleaner energy sources, he argues.
Oil companies are indeed showing growing interest. In Brazil, Petrobras is researching the possibility of natural hydrogen extraction. Oil giants BP and Chevron have joined a consortium studying natural hydrogen, and BP recently invested in UK-based natural hydrogen start-up Snowfox Discovery.
Others are considering stimulating hydrogen production by injecting water into underground iron-rich rocks to produce "orange" hydrogen, a process which could theoretically be coupled with carbon sequestration but remains more complicated and uncertain.
Zgonnik is optimistic white hydrogen can provide "the missing link" to decarbonise hard-to-abate sectors, starting with the fertiliser industry. Still, even under a best-case scenario, he estimates it could replace "only a few percent" of global fossil fuel use by 2050.
But others, like Truche, argue it is too early to determine what role, if any, white hydrogen could play in the energy transition. Whether replenishing reservoirs of extractable hydrogen exist underground "is a genuine scientific question", he says. "But it remains to be proven."
--
For essential climate news and hopeful developments to your inbox, sign up to the Future Earth newsletter, while The Essential List delivers a handpicked selection of features and insights twice a week.
For more science, technology, environment and health stories from the BBC, follow us on Facebook and Instagram.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
43 minutes ago
- The Independent
‘Fantastic Four: First Steps' scores Marvel's first $100 million box office opening of 2025
Marvel's first family has finally found box office gold. 'The Fantastic Four: First Steps,' the first film about the superheroes made under the guidance of Kevin Feige and the Walt Disney Co., earned $118 million in its first weekend in 4,125 North American theaters, according to studio estimates Sunday. That makes it the fourth biggest opening of the year, behind 'A Minecraft Movie,' 'Lilo & Stitch' and 'Superman,' and the biggest Marvel opening since 'Deadpool & Wolverine' grossed $211 million out of the gate last summer. Internationally, 'Fantastic Four' made $100 million from 52 territories, adding up to a $218 million worldwide debut. The numbers were within the range the studio was expecting. The film arrived in the wake of another big superhero reboot, James Gunn's 'Superman,' which opened three weekends ago and has already crossed $500 million globally. That film, from the other main player in comic book films, DC Studios, took second place with $24.9 million domestically. 'First Steps' is the latest attempt at bringing the superhuman family to the big screen, following lackluster performances for other versions. The film, based on the original Marvel comics, is set during the 1960s in a retro-futuristic world led by the Fantastic Four, a family of astronauts-turned-superhuman from exposure to cosmic rays during a space mission. The family is made up of Reed Richards (Pedro Pascal), who can stretch his body to incredible lengths; Sue Storm (Vanessa Kirby), who can render herself invisible; Johnny Storm (Joseph Quinn), who transforms into a fiery human torch; and Ben Grimm (Ebon Moss-Bachrach), who possesses tremendous superhuman strength with his stone-like flesh. The movie takes place four years after the family gained powers, during which Reed's inventions have transformed technology, and Sue's diplomacy has led to global peace. Both audiences and critics responded positively to the film, which currently has an 88% on Rotten Tomatoes and promising exit poll responses from opening weekend ticket buyers. An estimated 46% of audiences chose to see it on premium screens, including IMAX and other large formats. The once towering Marvel is working to rebuild audience enthusiasm for its films and characters. Its two previous offerings this year did not reach the cosmic box office heights of 'Deadpool & Wolverine," which made over $1.3 billion, or those of the 'Avengers'-era. But critically, the films have been on an upswing since the poorly reviewed 'Captain America: Brave New World,' which ultimately grossed $415 million worldwide. ' Thunderbolts," which jumpstarted the summer movie season, was better received critically but financially is capping out at just over $382 million globally. Like Deadpool and Wolverine, the Fantastic Four characters had been under the banner of 20th Century Fox for years. The studio produced two critically loathed, but decently profitable attempts in the mid-2000s with future Captain America Chris Evans as the Human Torch. In 2015, it tried again (unsuccessfully) with Michael B. Jordan and Miles Teller. They got another chance after Disney's $71 billion acquisition of Fox's entertainment assets in 2019. Top 10 movies by domestic box office With final domestic figures being released Monday, this list factors in the estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Comscore: 1. 'The Fantastic Four: First Steps,' $118 million. 2. 'Superman,' $24.9 million. 3. 'Jurassic World Rebirth,' $13 million. 4. 'F1: The Movie,' $6.2 million. 5. 'Smurfs,' $5.4 million. 6. 'I Know What You Did Last Summer,' $5.1 million. 7. 'How to Train Your Dragon,' $2.8 million. 8. 'Eddington,' $1.7 million. 9. 'Saiyaara,' $1.3 million. 10. 'Oh, Hi!,' $1.1 million.


The Independent
an hour ago
- The Independent
This fuzzy animal friend may be the key to treating schizophrenia
Llamas – likely without red pajamas – may hold the key to treating schizophrenia. The serious brain disorder causes people to interpret reality abnormally, and affects approximately 3.7 million U.S. adults between the ages of 18 to 65 years old, according to the nonprofit RTI International. But the domesticated South American woolly animal might be be able to help. French researchers said this week that they had used llama antibodies, or proteins that help to protect the immune system, to design a tiny fragment of an antibody known as a 'nanobody' that will trigger a neurotransmitter in the brain involved in regulating neural activity. Neurotransmitters are chemical molecules that carry messages or signals from one nerve cell to the next target cell, according to the Cleveland Clinic. No llamas were harmed in the study and researchers can identify nanobodies in a petri dish. In the past, llama antibodies have also proven effective in fighting Covid and other 'SARS-like' viruses. When scientists at the Institute of Functional Genomics injected the molecule into the veins or the muscles, it was able to break the blood-brain barrier and effectively reach brain receptors. The barrier is a a tightly locked layer of cells that defend your brain from harmful substances. Studying the impact of the nanobodies in two tests using mice, the researchers found that they corrected cognitive deficits that were observed. There was an improvement of cognitive function with just one shot, and a prolonged effect over one week. Clinical studies are now required to show that their findings could be a new avenue of treatment for schizophrenia. "In humans obviously we don't know [yet], but in mice yes, it is sufficient to treat most deficits of schizophrenia," molecular biologist Jean-Philippe Pin told Newsweek.. He was a co-author of the research which was published in the journal Nature. Pin said that medications currently given to schizophrenia patients "treat the symptoms well, but less the cognitive deficits." The cause of the chronic condition remains unknown, but the World Health Organization says it is thought that an interaction between genes and a range of environmental factors may be the reason. The exact prevalence of schizophrenia is difficult to measure. Some have tied cases in Canada to cannabis use. Although schizophrenia can occur at any age, people are typically diagnosed between the ages of 16 and 30. Symptoms vary from person to person. There is no cure, but it can be treated through antipsychotic medications, talk therapy, and self-management strategies, the National Alliance on Mental Illness says. The study's authors hope to add this strategy to the list. 'This research confirms the potential of nanobodies as a new therapeutic strategy for acting on the brain, with their use eventually being broadened to include the treatment of other neurological illnesses,' the institute said in a statement.


The Independent
2 hours ago
- The Independent
Millions of people are suffering from brain fog. A new study will find out why
Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms. These include chronic fatigue, brain fog, exercise intolerance, dizziness, muscle or joint pain and gut problems. And many of these symptoms worsen after exercise, a phenomenon known as post-exertional malaise. Medically the symptoms are known as myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). The World Health Organization classifies this as a post viral fatigue syndrome, and it is recognised by both the WHO and the United States Centers for Disease Control and Prevention as a brain disorder. Experiencing illness long after contracting an infection is not new, as patients have reported these symptoms for decades. But COVID-19 has amplified the problem worldwide. Nearly half of people with ongoing post-COVID symptoms – a condition known as long-COVID – now meet the criteria for ME/CFS. Since the start of the pandemic in 2020, it is estimated that more than 400 million people have developed long-COVID. To date, no widely accepted and testable mechanism has fully explained the biological processes underlying long-COVID and ME/CFS. Our work offers a new perspective that may help close this gap. Our research group studies blood and the cardiovascular system in inflammatory diseases, as well as post-viral conditions. We focus on coagulation, inflammation and endothelial cells. Endothelial cells make up the inner layer of blood vessels and serve many important functions, like regulating blood clotting, blood vessel dilation and constriction, and inflammation. Our latest review aims to explain how ME/CFS and long-COVID start and progress, and how symptoms show up in the body and its systems. By pinpointing and explaining the underlying disease mechanisms, we can pave the way for better clinical tools to diagnose and treat people living with ME/CFS and long-COVID. What is endothelial senescence? In our review, our international team proposes that certain viruses drive endothelial cells into a half-alive, 'zombie-like' state called cellular senescence. Senescent endothelial cells stop dividing, but continue to release molecules that awaken and confuse the immune system. This prompts the blood to form clots and, at the same time, prevent clot breakdown, which could lead to the constriction of blood vessels and limited blood flow. By placing 'zombie' blood-vessel cells at the centre of these post-viral diseases, our hypothesis weaves together microclots, oxygen debt (the extra oxygen your body needs after strenuous exercise to restore balance), brain-fog, dizziness, gut leakiness (a digestive condition where the intestinal lining allows toxins into the bloodstream) and immune dysfunction into a single, testable narrative. From acute viral infection to 'zombie' vessels Viruses like SARS-CoV-2, Epstein–Barr virus, HHV-6, influenza A, and enteroviruses (a group of viruses that cause a number of infectious illnesses which are usually mild) can all infect endothelial cells. They enable a direct attack on the cells that line the inside of blood vessels. Some of these viruses have been shown to trigger endothelial senescence. Multiple studies show that SARS-CoV-2 (the virus which causes COVID-19 disease) has the ability to induce senescence in a variety of cell types, including endothelial cells. Viral proteins from SARS-CoV-2, for example, sabotage DNA-repair pathways and push the host cell towards a senescent state, while senescent cells in turn become even more susceptible to viral entry. This reciprocity helps explain why different pathogens can result in the same chronic illness. Influenza A, too, has shown the ability to drive endothelial cells into a senescent, zombie-like state. What we think is happening We propose that when blood-vessel cells turn into 'zombies', they pump out substances that make blood thicker and prone to forming tiny clots. These clots slow down circulation, so less oxygen reaches muscles and organs. This is one reason people feel drained. During exercise, the problem worsens. Instead of the vessels relaxing to allow adequate bloodflow, they tighten further. This means that muscles are starved of oxygen and patients experience a crash the day after exercise. In the brain, the same faulty cells let blood flow drop and leak, bringing on brain fog and dizziness. In the gut, they weaken the lining, allowing bits of bacteria to slip into the bloodstream and trigger more inflammation. Because blood vessels reach every corner of the body, even scattered patches of these 'zombie' cells found in the blood vessels can create the mix of symptoms seen in long-COVID and ME/CFS. Immune exhaustion locks in the damage Some parts of the immune system kill senescent cells. They are natural-killer cells, macrophages and complement proteins, which are immune molecules capable of tagging and killing pathogens. But long-COVID and ME/CFS frequently have impaired natural-killer cell function, sluggish macrophages and complement dysfunction. Senescent endothelial cells may also send out a chemical signal to repel immune attack. So the 'zombie cells' actively evade the immune system. This creates a self-sustaining loop of vascular and immune dysfunction, where senescent endothelial cells persist. In a healthy person with an optimally functioning immune system, these senescent endothelial cells will normally be cleared. But there is significant immune dysfunction in ME/CFS and long-COVID, and this may enable the 'zombie cells' to survive and the disease to progress. Where the research goes next There is a registered clinical trial in the US that is investigating senescence in long-COVID. Our consortium is testing new ways to spot signs of ageing in the cells that line our blood vessels. First, we expose healthy endothelial cells in the lab to blood from patients to see whether it pushes the cells into a senescent, or 'zombie,' state. At the same time, we are trialling non‑invasive imaging and fluorescent probes that could one day reveal these ageing cells inside the body. In selected cases, tissue biopsies may later confirm what the scans show. Together, these approaches aim to pinpoint how substances circulating in the blood drive cellular ageing and how that, in turn, fuels disease. Our aim is simple: find these ageing endothelial cells in real patients. Pinpointing them will inform the next round of clinical trials and open the door to therapies that target senescent cells directly, offering a route to healthier blood vessels and, ultimately, lighter disease loads.